Close Menu
Aviation Analysis – Industry Travel NewsAviation Analysis – Industry Travel News
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Aviation Analysis – Industry Travel NewsAviation Analysis – Industry Travel News
    Subscribe
    • Home
    • Top News
    • World
    • Economy
    • Science
    • Tech
    • Sport
    • Entertainment
    • Contact Form
    Aviation Analysis – Industry Travel NewsAviation Analysis – Industry Travel News
    Home»Economy»At up to 60% efficacy, are AstraZeneca and Janssen vaccines working well enough?
    Economy

    At up to 60% efficacy, are AstraZeneca and Janssen vaccines working well enough?

    Jeffrey ClarkBy Jeffrey ClarkJanuary 30, 2021No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    At up to 60% efficacy, are AstraZeneca and Janssen vaccines working well enough?
    Share
    Facebook Twitter LinkedIn Pinterest Email Copy Link

    Plus, it’s not just about potency, but also Immunity Immunologist Van Els says. “This number indicates whether you are stimulating immunity with a vaccine. When this happens, the vaccine is activated and your immune system reacts. This way you train your immune system and your body defends itself faster in the event of a coronavirus infection.”

    Neutralizing antibodies are found in 99 percent of people vaccinated with the AstraZeneca vaccine. With the Janssen vaccine, preliminary data also indicates a high level of antibodies: between 82 and 94 percent. “That’s good news. Your immune system leads 1-0.”

    The spread of the virus is also reduced with the AstraZeneca vaccine. Toastman: “If the vaccine works very well against transmission, that’s also a big advantage.”

    Other vaccines for the elderly?

    With the AstraZeneca vaccine, there are also concerns on social media about the small amount of data available on protection for those over 55. According to experts, these concerns are unnecessary. “It would be strange if a vaccine would work until the age of 55 and then suddenly stop working after 55 years,” says Frits Roosendaal. “The reason there is no data is related to the fact that very few people over 55 took part in the study. Not with the vaccine.”

    However, the lack of data may be a reason for modifying the vaccination strategy and administering a different vaccine to the elderly, and its effectiveness has been proven. “Maybe you should choose Pfizer or Moderna Seniors,” Rosendal says.

    Van der Zeijst also believes that vulnerable groups should not be given the Janssen or AstraZeneca vaccines, if there is a choice. “But it is possible that people over the age of 65 will not receive these vaccines, because we in the Netherlands only want to use RNA vaccines in the elderly.” The vaccines from AstraZeneca and Janssen are based on so-called carrier technology.

    What is the difference and how vaccines can protect you, you can see in the video:

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Jeffrey Clark

    Avid music fanatic. Communicator. Social media expert. Award-winning bacon scholar. Alcohol fan.

    Related Posts

    USDA Expands Food Safety Certification Assistance to Medium-Sized Specialty Crop Growers

    August 21, 2025

    USDA Reminds Farmers of Compliance Rules for Land and Wetland Conservation Programs

    August 21, 2025

    USDA’s Farm Storage Loan Program Marks 25 Years of Supporting Farmers

    August 21, 2025
    Navigate
    • Home
    • Top News
    • World
    • Economy
    • Science
    • Tech
    • Sport
    • Entertainment
    • Contact Form
    Pages
    • About Us
    • DMCA
    • Contact Form
    • Privacy Policy
    • Editorial Policy
    STAY UPTODATE

    Get the Latest News With Aviationanalysis.net

    OFFICE

    X. Herald Inc.
    114 5th Ave New York,
    NY 10011, United States

    QUERIES?

    Do you have any queries? Feel free to contact us via our Contact Form

    Visit Our Office

    X. Herald Inc.
    114 5th Ave New York,
    NY 10011, United States

    • About Us
    • DMCA
    • Contact Form
    • Privacy Policy
    • Editorial Policy
    © 2025 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.